Papillary Thyroid Cancer Clinical Trials

14 recruiting

Frequently Asked Questions

Common questions about Papillary Thyroid Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Radiofrequency AblationPapillary Thyroid CancerLow Risk
M.D. Anderson Cancer Center50 enrolled1 locationNCT07140757
Recruiting

Studies on Tumors of the Thyroid

Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,500 enrolled1 locationNCT00001160
Recruiting

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Papillary Thyroid Cancer
University of Calgary130 enrolled1 locationNCT06133374
Recruiting

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Pediatric CancerPapillary Thyroid CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia32 enrolled9 locationsNCT05024929
Recruiting

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

Papillary Thyroid Cancer
Chinese PLA General Hospital3,000 enrolled1 locationNCT06733740
Recruiting
Not Applicable

A Study of Online Follow-up in Patients With Papillary Thyroid Cancer

Papillary Thyroid CancerThyroid
West China Hospital388 enrolled1 locationNCT06800482
Recruiting
Phase 3

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University400 enrolled1 locationNCT06791005
Recruiting
Phase 2

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Thyroid CancerThyroid CarcinomaPapillary Thyroid Cancer+3 more
Massachusetts General Hospital30 enrolled6 locationsNCT05668962
Recruiting

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Papillary Thyroid Cancer
Chinese PLA General Hospital3,772 enrolled1 locationNCT06316895
Recruiting

Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY

Papillary Thyroid Cancer
Istituto Auxologico Italiano600 enrolled1 locationNCT05766098
Recruiting

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
National Taiwan University Hospital103 enrolled1 locationNCT04948437
Recruiting
Not Applicable

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Lymph Node MetastasisPapillary Thyroid CancerCarcinogenesis
Second Affiliated Hospital of Xi'an Jiaotong University170 enrolled1 locationNCT06468696
Recruiting
Not Applicable

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Papillary Thyroid Cancer
Zhujiang Hospital254 enrolled1 locationNCT04354324
Recruiting

Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale

Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University800 enrolled1 locationNCT06286631